View in EDS HTML Full Text PDF Full Text

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.

Saved in:
Bibliographic Details
Title: Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
Authors: Coussy, F.1,2,3 (AUTHOR) florence.coussy@curie.fr, El Botty, R.2 (AUTHOR), Lavigne, M.4 (AUTHOR), Gu, C.4 (AUTHOR), Fuhrmann, L.4 (AUTHOR), Briaux, A.1 (AUTHOR), de Koning, L.5 (AUTHOR), Dahmani, A.2 (AUTHOR), Montaudon, E.2 (AUTHOR), Morisset, L.2 (AUTHOR), Huguet, L.2 (AUTHOR), Sourd, L.2 (AUTHOR), Painsec, P.2 (AUTHOR), Chateau-Joubert, S.6 (AUTHOR), Larcher, T.7 (AUTHOR), Vacher, S.1 (AUTHOR), Melaabi, S.1 (AUTHOR), Salomon, A. Vincent4 (AUTHOR), Marangoni, E.2 (AUTHOR), Bieche, I.1,8 (AUTHOR)
Source: Journal of Hematology & Oncology. 2/22/2020, Vol. 13 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-020-0846-y